Publication | Closed Access
A randomised controlled trial of high-dose isoniazid adjuvant therapy for multidrug-resistant tuberculosis.
138
Citations
0
References
2008
Year
In low-resource scenarios where a standardised therapeutic protocol is used for MDR-TB, the protocol can be significantly improved by including high-dose INH as an adjuvant.